Literature DB >> 11470419

PTEN.

D Stokoe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11470419     DOI： 10.1016/s0960-9822(01)00303-7

Source DB:  PubMed          Journal:  Curr Biol        ISSN： 0960-9822            Impact factor:   10.834


× No keyword cloud information.
  21 in total

1.  Understanding the stereospecific interactions of 3-deoxyphosphatidylinositol derivatives with the PTEN phosphatase domain.

Authors:  Qin Wang; Yang Wei; Madhusoodanan Mottamal; Mary F Roberts; Goran Krilov
Journal:  J Mol Graph Model       Date:  2010-05-20       Impact factor: 2.518

Review 2.  Targeting the PI3-kinase/Akt/mTOR signaling pathway.

Authors:  Burhan Hassan; Argun Akcakanat; Ashley M Holder; Funda Meric-Bernstam
Journal:  Surg Oncol Clin N Am       Date:  2013-08-06       Impact factor: 3.495

3.  Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.

Authors:  Naghma Khan; Farrukh Afaq; Fatima H Khusro; Vaqar Mustafa Adhami; Yewseok Suh; Hasan Mukhtar
Journal:  Int J Cancer       Date:  2011-08-26       Impact factor: 7.396

Review 4.  Coincidence detection in phosphoinositide signaling.

Authors:  Jez G Carlton; Peter J Cullen
Journal:  Trends Cell Biol       Date:  2005-10       Impact factor: 20.808

5.  Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids.

Authors:  Shuhua Xia; Yan Lu; Jingdong Wang; Chengwei He; Song Hong; Charles N Serhan; Jing X Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-03       Impact factor: 11.205

Review 6.  Predictive and prognostic markers in colorectal cancer.

Authors:  Ben George; Scott Kopetz
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

7.  cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a.

Authors:  Xiaochao Tan; Shan Wang; Liyuan Zhu; Chao Wu; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 8.  Inhibiting PI3K as a therapeutic strategy against cancer.

Authors:  Luis Paz-Ares; Carmen Blanco-Aparicio; Rocío García-Carbonero; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

Review 9.  Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

Authors:  Jaclyn LoPiccolo; Gideon M Blumenthal; Wendy B Bernstein; Phillip A Dennis
Journal:  Drug Resist Updat       Date:  2007-12-31       Impact factor: 18.500

Review 10.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.